GSN and diabetic kidney disease: A decrease of gelsolin in plasma may be involved in ROS production and inflammation which promotes PKC activation and causes kidney damage in diabetic nephropathy (Cheng et al., 2017[7]; Li et al., 2009[27]; Lu et al., 2019[29]; Sagawa et al., 2003[48]).